KRW 27400.0
(8.3%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 285.93 Billion KRW | 6.96% |
2022 | 264.51 Billion KRW | 8.33% |
2021 | 244.18 Billion KRW | 12.24% |
2020 | 217.56 Billion KRW | 9.72% |
2019 | 198.28 Billion KRW | 9.72% |
2018 | 180.72 Billion KRW | 16.05% |
2017 | 155.73 Billion KRW | 74.61% |
2016 | 89.19 Billion KRW | 0.0% |
2014 | 94.44 Billion KRW | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 73.09 Billion KRW | 4.76% |
2024 Q2 | 71.36 Billion KRW | -2.36% |
2023 Q2 | 74.09 Billion KRW | 9.89% |
2023 FY | 282.92 Billion KRW | 6.96% |
2023 Q4 | 69.77 Billion KRW | 0.41% |
2023 Q1 | 67.42 Billion KRW | -2.36% |
2023 Q3 | 69.49 Billion KRW | -6.21% |
2022 Q2 | 65.62 Billion KRW | 1.5% |
2022 Q4 | 69.05 Billion KRW | 6.95% |
2022 Q3 | 64.57 Billion KRW | -1.61% |
2022 Q1 | 64.65 Billion KRW | 4.64% |
2022 FY | 264.51 Billion KRW | 8.33% |
2021 Q2 | 63.62 Billion KRW | 13.45% |
2021 FY | 244.18 Billion KRW | 12.24% |
2021 Q1 | 56.08 Billion KRW | 0.12% |
2021 Q4 | 61.78 Billion KRW | -2.26% |
2021 Q3 | 63.21 Billion KRW | -0.65% |
2020 Q3 | 58.35 Billion KRW | 5.81% |
2020 Q1 | 50.15 Billion KRW | -8.91% |
2020 Q2 | 55.14 Billion KRW | 9.95% |
2020 FY | 217.56 Billion KRW | 9.72% |
2020 Q4 | 56.01 Billion KRW | -4.01% |
2019 Q2 | 46.71 Billion KRW | 0.45% |
2019 FY | 198.28 Billion KRW | 9.72% |
2019 Q4 | 55.06 Billion KRW | 6.98% |
2019 Q3 | 51.47 Billion KRW | 10.18% |
2019 Q1 | 46.5 Billion KRW | 2.17% |
2018 FY | 180.72 Billion KRW | 16.05% |
2018 Q2 | 45.79 Billion KRW | 8.83% |
2018 Q3 | 47.55 Billion KRW | 3.84% |
2018 Q1 | 42.08 Billion KRW | 2.21% |
2018 Q4 | 45.52 Billion KRW | -4.28% |
2017 Q1 | 35.54 Billion KRW | -54.52% |
2017 FY | 155.73 Billion KRW | 74.61% |
2017 Q4 | 41.17 Billion KRW | 2.62% |
2017 Q3 | 40.12 Billion KRW | 4.94% |
2017 Q2 | 38.23 Billion KRW | 7.56% |
2016 Q3 | 32.81 Billion KRW | 0.0% |
2016 FY | 89.19 Billion KRW | 0.0% |
2016 Q4 | 78.16 Billion KRW | 138.21% |
2014 FY | 94.44 Billion KRW | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
HLB Pharmaceutical Co., Ltd | 82.98 Billion KRW | -244.566% |
CMG Pharmaceutical Co., Ltd. | 43.7 Billion KRW | -554.283% |
Celltrion Pharm, Inc. | 116.95 Billion KRW | -144.476% |
Huons Global Co., Ltd. | 417.8 Billion KRW | 31.561% |
DongKook Pharmaceutical Co., Ltd. | 405.04 Billion KRW | 29.405% |
Enzychem Lifesciences Corporation | 3.29 Billion KRW | -8581.951% |
Humedix Co., Ltd. | 68.04 Billion KRW | -320.223% |
Boditech Med Inc. | 76.7 Billion KRW | -272.778% |
EuBiologics Co., Ltd. | 32.65 Billion KRW | -775.528% |
FutureChem Co.,Ltd | 758.27 Million KRW | -37609.386% |
BNC Korea Co., Ltd. | 31.97 Billion KRW | -794.173% |
AptaBio Therapeutics Inc. | 78.49 Million KRW | -364159.372% |